AirDuo Digihaler
Drug Respiratory
NDC 59310-111-06
General payments
$542,064
Research payments
$459,477
Through program year 2024, $542,064 in general payments and $459,477 in research payments were reported against AirDuo Digihaler (Respiratory).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $2,997 | 7 |
| 2024 | Research | $64,483 | 5 |
| 2023 | General | $40,870 | 1,032 |
| 2022 | General | $135,005 | 7,517 |
| 2022 | Research | $1,960 | 2 |
| 2021 | General | $208,567 | 12,603 |
| 2021 | Research | $393,035 | 8 |
| 2020 | General | $154,625 | 972 |
Breakdown
The top 5 of 7 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
22,131 general · 15 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.